Primary |
Seasonal Allergy |
30.8% |
Asthma |
26.9% |
Respiratory Tract Infection |
19.2% |
Product Used For Unknown Indication |
11.5% |
Asthma Exercise Induced |
3.8% |
Atrial Septal Defect |
3.8% |
Dyspnoea |
3.8% |
|
Exposure During Pregnancy |
11.1% |
Limb Reduction Defect |
11.1% |
Overdose |
11.1% |
Rash Pustular |
11.1% |
Tachycardia |
11.1% |
Throat Irritation |
11.1% |
Tonic Clonic Movements |
11.1% |
Vomiting |
11.1% |
Wound |
11.1% |
|
Secondary |
Product Used For Unknown Indication |
53.0% |
Asthma |
12.0% |
Bronchitis |
5.1% |
Acute Sinusitis |
3.4% |
General Anaesthesia |
3.4% |
Prophylaxis |
3.4% |
Pain |
2.6% |
Respiratory Failure |
2.6% |
Arrhythmia |
1.7% |
Cholangiocarcinoma |
1.7% |
Chronic Obstructive Pulmonary Disease |
1.7% |
Cystitis |
1.7% |
Schizoaffective Disorder |
1.7% |
Antibiotic Prophylaxis |
0.9% |
Anxiety |
0.9% |
Atrial Fibrillation |
0.9% |
Bipolar Disorder |
0.9% |
Cerebrovascular Accident |
0.9% |
Cerebrovascular Accident Prophylaxis |
0.9% |
Genitalia External Ambiguous |
0.9% |
|
Death |
14.3% |
Pancreatic Carcinoma |
9.5% |
Pancreatitis Acute |
9.5% |
Rash Pustular |
9.5% |
Dyspnoea |
4.8% |
Exposure During Pregnancy |
4.8% |
Neuropathy Peripheral |
4.8% |
Paraesthesia |
4.8% |
Pleurisy |
4.8% |
Renal Tubular Disorder |
4.8% |
Respiratory Disorder |
4.8% |
Stasis Dermatitis |
4.8% |
Syncope |
4.8% |
Tremor |
4.8% |
Vomiting |
4.8% |
Weight Decreased |
4.8% |
|
Concomitant |
Product Used For Unknown Indication |
40.6% |
Asthma |
13.2% |
Chronic Obstructive Pulmonary Disease |
7.5% |
Hypertension |
6.2% |
Rheumatoid Arthritis |
3.3% |
Hiv Infection |
2.9% |
Haemolytic Uraemic Syndrome |
2.8% |
Drug Use For Unknown Indication |
2.6% |
Prophylaxis |
2.4% |
Pain |
2.3% |
Type 2 Diabetes Mellitus |
2.3% |
Epilepsy |
2.0% |
Atrial Fibrillation |
1.8% |
Cystic Fibrosis |
1.8% |
Diabetes Mellitus |
1.8% |
Bronchitis |
1.6% |
Anxiety |
1.3% |
Gastrooesophageal Reflux Disease |
1.3% |
Lung Disorder |
1.3% |
Depression |
1.1% |
|
Renal Failure Acute |
14.3% |
Vomiting |
10.4% |
Hypogammaglobulinaemia |
7.8% |
Pyrexia |
6.5% |
Weight Decreased |
6.5% |
Wheezing |
6.5% |
Pancytopenia |
5.2% |
Hepatocellular Injury |
3.9% |
Pneumonia |
3.9% |
Renal Failure |
3.9% |
Somnolence |
3.9% |
Thrombotic Microangiopathy |
3.9% |
Transaminases Increased |
3.9% |
Vasculitis |
3.9% |
Cardio-respiratory Arrest |
2.6% |
Diarrhoea |
2.6% |
Drug Ineffective |
2.6% |
Headache |
2.6% |
Hepatitis |
2.6% |
Infective Exacerbation Of Bronchiectasis |
2.6% |
|